|
|
|
|
Twice-Daily ARV Treatment Better than Once-Daily for Some
Even though people living with HIV may be more likely to adhere to a Kaletra (lopinavir/ritonavir)-based treatment regimen taken once a day compared with twice a day, those with high pre-treatment viral loads may experience virologic failure faster using ...
|
|
|
Revised Intelence Labeling Approved
The FDA has approved revised labeling for Tibotec Therapeutics Intelence (etravirine) to include drug-drug interaction information between etravirine and fluconazole (eg, Diflucan), voriconazole (Vfend), lopinavir/ritonavir (Kaletra) tablets, and...
|
|
|
HIV-positive boys have reduced bone density
HIV-positive pubescent boys have significantly lower bone mineral content and density than their HIV-negative peers, US investigators report in the online edition of AIDS.The researchers also found that treatment with Kaletra was associated with...
|
|
|
Antivirals: Novel Targets, Technologies, and Dealmaking
The hottest field in antivirals is hepatitis C virus (HCV) drug development; compounds against novel HCV targets such as NS3/4A protease, NS5B polymerase, and NS5A hold the promise of revolutionizing the treatment of this disease.Targeted antivirals have...
|
|
|
FDA Notifications
On Jan.29, 2009, the Food and Drug Administration (FDA) approved revisions to the lopinavir/ritonavir (Kaletra ) package insert to include drug-drug interaction information for concurrent lopinavir/ritonavir administration with inhaled medicines such...
|
|
|
Invirase Data Spark Warning: Possible PI Combo Heart Risk
Developers and sellers of protease inhibitors were taking in cautious stride an FDA warning related to preliminary data that suggested Invirase (saquinavir), from Roche Holding Ltd., when combined in the usual way with Abbott's Norvir (ritonavir), another...
|
|
|
Two experts weigh in on how to manage
An HIV-infected pregnant woman says she's taking her antiretrovirals but the blood test results say otherwise.Two experts describe their approach to management. A few weeks ago, we described the case of an HIV-infected pregnant woman whose medication...
|
|
|
UNITED STATES: Abbott Heat-Stable HIV Meds OK'd
A new formulation of Abbott Laboratories' antiretroviral Norvir has been approved by the US Food and Drug Administration.Abbott used its proprietary Meltrex melt- extrusion process to create the new formulation, which can be stored at room temperature and...
|
|
|
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir (ritonavir) Tablets
Abbott announced that the U.S.Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir (ritonavir). The new Norvir tablets can be stored at room temperature and do not require...
|
|
|
Abbott Receives U.S. FDA Approval For Heat-Stable Norvir (Ritonavir) Tablets
Abbott Park, IL /PRNewswire-FirstCall/ - Abbott (NYSE: ABT) announced today that the U.S.Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir (ritonavir). The new Norvir...
|
|
|
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir (ritonavir) Tablets
ABBOTT PARK, Ill., Feb.11 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir (ritonavir). The new...
|
|
|
Abbott wins FDA approval for HIV drug
(Datamonitor via COMTEX) Abbott has announced that the FDA has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir.The new Norvir tablets can be stored at room temperature and do not require refrigeration, making it...
|
|
|
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets - HIV Access Programs in the U
ABBOTT PARK, Ill., Feb.11 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir (ritonavir). The...
|
|
|
2/12/10 - Abbott wins FDA approval for HIV drug
(Datamonitor via COMTEX) Abbott has announced that the FDA has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir.The new Norvir tablets can be stored at room temperature and do not require refrigeration, making it...
|
|
|
Abbott Receives U.S. FDA Approval For Heat-Stable Norvir(R) (ritonavir) Tablets
Abbott announced today that the U.S.Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir (ritonavir). The new Norvir tablets can be stored at room temperature and do not...
|
|
|
2/11/10 - Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
ABBOTT PARK, Ill., Feb.11 /PRNewswire-FirstCall/ Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the companyescape_start39;s antiretroviral medication Norvir (ritonavir...
|
|
|
How would you manage?
22 AM EST The possibility of nonadherence must be considered.Assuming that she is adherent as she claims, possible explanations of lack of... [more] counselling maurizio setti, San Martino University Hospital, Genoa, Italy, 9 Feb 2010 3:45 AM EST First:...
|
|
|
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
ABBOTT PARK, Ill., Feb.11 /PRNewswire-FirstCall/ Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the companyescape_start39;s antiretroviral medication Norvir (ritonavir...
|
|
|
FDA Approves New Heat-stable Ritonavir (Norvir) Tablet
Below is an excerpt from an Abbott community announcement describing the approval: February 10, 2010 Abbott is pleased to announce the U.S.Food and Drug Administration (FDA) approval of the new tablet formulation of our protease inhibitor (PI) Norvir ...
|
|
|
FDA Approves New Norvir Tablet for Use - from Abbott
Abbott is pleased to announce the U.S.Food and Drug Administration (FDA) approval of the new tablet formulation of our protease inhibitor (PI) Norvir (ritonavir). This new heat-stable formulation can be stored at room temperature and does not require...
|
|
|
FDA Approves Abbott's Heat-Stable Version Of Norvir HIV/AIDS Drug - Update
2/11/2010 4:33 PM ET RELATED NEWS Trade ABT now with TOP MARKET NEWS (RTTNews) - Thursday, pharmaceutical giant Abbott Laboratories (ABT: News ) said the U.S.Food and Drug Administration granted approval for a 'heat-stable' tablet formulation of its...
|
|
|
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
Companies mentioned in this article: Abbott ABBOTT PARK, Ill., Feb.11 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's...
|
|
|
Is She or Isn't She?
An HIV-infected pregnant woman says she's taking her antiretrovirals but the blood test results say otherwise.How would you manage? A woman in her 30s entered the clinic, 16 weeks pregnant, to reestablish care for her HIV infection and to start...
|
